RenovoRx, Inc. — Investor Relations & Filings
Filings indexed
260
across all filing types
Latest filing
2026-05-15
Annual Report
Country
US
United States of America
Listing
US
RNXT
RenovoRx, Inc. is a clinical-stage life sciences company developing targeted oncology therapies for solid tumors. The company's core technology is its proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform, which is designed for the localized delivery of therapeutic agents directly to tumors. This approach aims to enhance treatment efficacy while minimizing the systemic toxicities associated with conventional intravenous chemotherapy. The TAMP platform is enabled by the RenovoCath®, an FDA-cleared dual-balloon infusion catheter that isolates blood flow for targeted drug delivery. RenovoRx is advancing its lead drug-device combination product candidate in the Phase III TIGeR-PaC clinical trial for the treatment of locally advanced pancreatic cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A | 2026-05-15 | English | |
| 8-K | 2026-05-14 | English | |
| DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | |
| 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | |
| S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | |
| 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46363239 | 10-K/A | 2026-05-15 | English | ||
| 46274549 | 8-K | 2026-05-14 | English | ||
| 39207996 | DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | ||
| 37646430 | 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | ||
| 34650376 | S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | ||
| 33058807 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058608 | 3/A - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058261 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-27 | English | ||
| 33036308 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036307 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036306 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036294 | 3 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33012729 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-23 | English | ||
| 30649394 | 8-K Filing | 2026-02-06 | English | ||
| 30649391 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies…
|
ANVS | US | Professional, scientific and te… |
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
|
ANTEOTECH LTD
Develops nanoglue technology for life sciences and lithium-…
|
ADO | AU | Professional, scientific and te… |
|
Anthem Biosciences Limited
Integrated CRAMS organization for drug discovery, developme…
|
ANTHEM | IN | Professional, scientific and te… |
|
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for geneti…
|
APDN | US | Professional, scientific and te… |
|
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via…
|
APRE | US | Professional, scientific and te… |
|
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases…
|
397030 | KR | Professional, scientific and te… |
|
Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for…
|
APTA | SE | Professional, scientific and te… |
|
APTAMER GROUP PLC
Develops custom affinity binders for research, diagnostics,…
|
APTA | GB | Professional, scientific and te… |
|
Aptevo Therapeutics Inc.
Clinical-stage biotech developing antibody-based immunother…
|
APVO | US | Professional, scientific and te… |
RenovoRx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34656/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34656 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34656 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34656 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34656}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RenovoRx, Inc. (id: 34656)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.